Youth Protection Forum
The Sultan Sharif Ali Mosque's Syababul Iman Group organised the 7th Youth Protection Forum Series titled Mental Health: Journey Towards Healing. Held on 11th...
Throwing Rubbish in Public Areas
Two individuals were issued compound fines for the offence of throwing rubbish in public areas at the Sultan Haji Omar Ali Saifuddien Bridge under...
‘Costume Fun Run’
In conjunction with the Brunei December Festival, a 3-kilometre Costume Fun Run was held on 11th December morning. The event started and ended at...
Exploring Places of Interest using Application
63 participants took part in the Dynamik Amazing Scavenger Hunt, 11th December morning. The event was organised by Dynamik Technologies in conjunction with the...
French Culture and Petanque Day
The French Culture and Petanque Day organised by Alliance Francaise de Brunei Darussalam in cooperation with the Brunei Darussalam Petanque Federation aimed to educate...
Japanese Culture Festival
The Embassy of Japan in Brunei Darussalam in collaboration with Times Square Sjopping Centre and Japan Foundation held a two day Japanese Culture Festival....
Day of Action Campaign Activity
The Day of Action Campaign was also held in the other three districts. For Brunei Muara District, the event began at Sungai Kebun Sports...
Launch of Day of Action Campaign
Brunei Darussalam through the Ministry of Culture, Youth and Sports held a Day of Action Campaign, in conjunction with International Volunteer Day 2022 celebration,...
The Alpha Challenge 2022
A number of events in conjunction with the 6th Brunei December Festival continued to be held on 11th December. Among them was the Alpha...
Junshi Biosciences Announces Updated Clinical data from Phase I study of anti-BTLA antibody Tifcemalimab...
— Preliminary study results show that tifcemalimab is well-tolerated at all administered doses. The observed clinical activity of tifcemalimab in combination with toripalimab in lymphoma patients refractory to checkpoint inhibitors warrants further evaluation. Combination dose expansion is under way. — Among the 28 evaluable patients who received the combination regimen, while 85.7% of the patients […]